Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

SPHK1 antibody

This Mouse Monoclonal antibody specifically detects SPHK1 in FACS. It exhibits reactivity toward Human and Mouse.
Catalog No. ABIN2665362

Quick Overview for SPHK1 antibody (ABIN2665362)

Target

See all SPHK1 Antibodies
SPHK1 (Sphingosine Kinase 1 (SPHK1))

Reactivity

  • 97
  • 42
  • 38
  • 9
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
Human, Mouse

Host

  • 88
  • 9
  • 1
Mouse

Clonality

  • 82
  • 16
Monoclonal

Conjugate

  • 58
  • 6
  • 4
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This SPHK1 antibody is un-conjugated

Application

  • 72
  • 40
  • 24
  • 22
  • 13
  • 13
  • 11
  • 11
  • 7
  • 4
  • 3
  • 3
  • 2
  • 2
Flow Cytometry (FACS)

Clone

1A5SC
  • Purification

    The antibody was purified by affinity chromatography.

    Isotype

    IgG1
  • Application Notes

    Optimal working dilution should be determined by the investigator.

    Restrictions

    For Research Use only
  • Concentration

    0.5 mg/mL

    Buffer

    Phosphate-buffered solution, pH 7.2, containing 0.09 % sodium azide.

    Preservative

    Sodium azide

    Precaution of Use

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    4 °C

    Storage Comment

    The antibody solution should be stored undiluted between 2°C and 8°C.
  • Target

    SPHK1 (Sphingosine Kinase 1 (SPHK1))

    Alternative Name

    SPHK1

    Background

    SPHK1 is a lipid kinase that catalyzes the phosphorylation of sphingosine to sphingosine-1-phosphate (S1P) which is a key sphingolipid signaling molecule involved in cell growth, survival, differentiation, and motility. As an important regulator of ceramide, sphingosine, and S1P, SPHK1 plays important roles in immunological, inflammatory diseases, and cancer. SPHK1 is overexpressed in various types of cancers, and upregulation of SPHK1 has been associated with tumor angiogenesis and resistance to radiation and chemotherapy. Agents targeting the SPHK1 have the potential as therapeutics for cancer, immunological, and inflammatory disorders.

    Pathways

    VEGF Signaling
You are here:
Chat with us!